Connect with us

Technology

Scientific Instrument Market size is set to grow by USD 19.96 billion from 2024-2028, Increasing investments in drug discovery boost the market, Technavio

Published

on

NEW YORK, July 31, 2024 /PRNewswire/ — The global scientific instrument market size is estimated to grow by USD 19.96 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 5.45% during the forecast period. Increasing investments in drug discovery is driving market growth, with a trend towards growing adoption of portable scientific instruments. However, lack of trained professionals poses a challenge. Key market players include ABB Ltd., ACMAS Technologies Pvt. Ltd., Agilent Technologies Inc., Alcon Scientific, Bio Rad Laboratories Inc., Bruker Corp., Carl Zeiss AG, Danaher Corp., Hitachi Ltd., HORIBA Ltd., Labappara, M.K.Scientific Instruments, MAC, Merck KGaA, Oxford Instruments plc, Shimadzu Corp., SM Scientific Instruments Pvt. Ltd., Thermo Fisher Scientific Inc., Thorlabs Inc., and Waters Corp..

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Scientific Instrument Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 5.45%

Market growth 2024-2028

USD 19966.9 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

4.77

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 34%

Key countries

US, China, Germany, UK, and India

Key companies profiled

ABB Ltd., ACMAS Technologies Pvt. Ltd., Agilent Technologies Inc., Alcon Scientific, Bio Rad Laboratories Inc., Bruker Corp., Carl Zeiss AG, Danaher Corp., Hitachi Ltd., HORIBA Ltd., Labappara, M.K.Scientific Instruments, MAC, Merck KGaA, Oxford Instruments plc, Shimadzu Corp., SM Scientific Instruments Pvt. Ltd., Thermo Fisher Scientific Inc., Thorlabs Inc., and Waters Corp.

 

Market Driver

The scientific instrument market is experiencing a significant shift towards miniaturized and portable equipment due to the need for space efficiency and convenience in laboratory settings. Vendors are redesigning industry-standard instruments using miniaturization technologies such as fluidics and integrated printed circuit boards (PCBs) to create compact versions of laboratory equipment. Traditional scientific instruments often have complex wiring and components at the bottom and rear, but miniaturization allows for the removal of these elements, making the equipment more compact. Advancements in sensors and wireless connectivity further enable the creation of portable instruments, freeing them from the need for complex wires and cables. Integration of multiple laboratory functions and features onto a single chip through very large-scale integration technologies also saves money, space, and manpower for both vendors and end-users. Miniaturization and nanotechnology have revolutionized point-of-care testing and led to the manufacturing of portable equipment like miniaturized centrifuges from companies such as Bio-Rad Laboratories, Thermo Fisher Scientific, and Merck. These portable analyzers offer quick decision-making capabilities with advanced technologies like X-ray fluorescence (XRF), near-infrared (NIR), Raman, and Fourier transform infrared spectroscopy (FTIR), and an easy-to-use interface. The benefits of miniaturized and portable scientific instruments are driving their demand, and this trend is expected to continue during the forecast period. 

The Scientific Instruments market is thriving, driven by trends in various sectors. Product microscopes, spectrometers, X-ray diffraction, thermal analyzers, and other lab equipment are in high demand. Handheld and portable instruments are popular for field research in healthcare companies, retail sales, and online sales. Biotechnology, materials science, environmental science, private organizations, and academic institutions are major buyers. Electron microscopes, mass spectrometers, DNA sequencers, particle accelerators, and molecular analyzers are key tools for precision medicine, genetic sequencing, drug development, and molecular interactions. Biomarker detection systems, drug safety, and automated solutions are essential for disease mechanisms research in genomics and proteomics. Pharmaceutical companies, analytical instruments manufacturers, startups, and research institutions are investing heavily in this sector. Trends include portable instruments, data analysis, drug safety, and solutions for chronic and target diseases. 

Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!

Market Challenges

The scientific instrument market is experiencing significant technological advancements at an accelerated pace. Keeping up-to-date with these changes and maintaining a workforce with advanced technical skills is a challenge for end-users due to the high costs of training. Calibration of scientific instruments is crucial for accurate results, yet line inspectors may not possess the necessary technical capabilities. Additionally, interpreting data from these instruments and effectively handling accompanying software requires specialized knowledge. The scarcity of professionals with both medical expertise and software proficiency, coupled with frequent software upgrades and increasing instrument features, poses a critical challenge to the growth of the global scientific instrument market.The Scientific Instrument Market faces several challenges in various sectors. In the healthcare industry, accurate measurement and analysis of urine, tissue, glucose levels, cholesterol levels, and blood cell counts are crucial for medical diagnosis and treatment planning. Infectious diseases, cancer, and chronic conditions like diabetes, respiratory diseases, and cardiovascular diseases require advanced diagnostic tools. Clinical laboratories and hospitals rely on clinical analyzers for quick and accurate results. The biotech and pharmaceutical research sectors need instruments for measuring physical quantities, remodeling, and theoretical research. In the pharmaceutical sectors, verifying the efficacy of therapeutics is essential. Public health emergencies require rapid diagnostic tools for outpatients and inpatients. The research segment focuses on developing instruments for mutated diseases and neurological diseases. Laboratory automation is a key trend to improve efficiency and reduce errors. Overall, meeting the demands of these sectors while ensuring accuracy, reliability, and affordability is a significant challenge for the Scientific Instrument Market.

For more insights on driver and challenges – Request a sample report!

Segment Overview 

This scientific instrument market report extensively covers market segmentation by

Product 1.1 Laboratory analytical instruments and consumables1.2 Measuring and monitoring devicesEnd-user 2.1 Pharmaceutical and biotechnology companies2.2 Hospitals and diagnostic laboratories2.3 OthersGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Laboratory analytical instruments and consumables- The global scientific instrument market’s laboratory analytical instruments and consumables segment encompasses mass spectrometers, chromatographs, and other tools that assist in diagnosing and analyzing specific infections. These instruments are extensively utilized in life science research, particularly in metabolomics, genomics, and proteomics, employing spectroscopy, mass spectrometry, electrochemical analysis, thermal analysis, separation analysis, and microscopy. The pharmaceutical industry is witnessing a growing demand for Raman spectroscopy to develop new drugs. Raman spectroscopy employs spectrometers and the spectroscopic technique to uncover the chemical structure, concentration, identity, and behavior of molecules in various forms. In pharmaceuticals, Raman spectroscopy is utilized for drug discovery by defining the structural composition of therapeutic drug agents and investigating intermolecular interactions. Post-approval, it ensures the correct compound’s manufacturing and guards against hazardous substances from packaging. Consumables, including funnels, flasks, syringes, and needles, are crucial for drug development and significantly contribute to market expansion due to recurring purchases for diverse testing purposes. Reagents and buffers are among the essential consumables, with their repeated usage in scientific tests and experiments. The variety of reagents required for different testing objectives presents an opportunity for consumables manufacturers to cater to end-users’ diverse needs. Technological advances in reaction buffers have resulted in heightened stability and longevity for reagents and enzymes, driving the growth of the laboratory analytical instruments and consumables segment and the market as a whole.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Research Analysis

The scientific instrument market encompasses a wide range of tools used for measuring, analyzing, verifying, and understanding physical quantities in various sectors. Key product categories include microscopes for observing and examining samples at the microscopic level, spectrometers for identifying and quantifying materials based on their light interaction, X-ray diffraction for determining crystal structures, and thermal analyzers for studying material properties under temperature changes. Handheld and benchtop instruments, as well as portable versions, cater to field research and on-site analysis. Laboratories in pharmaceutical sectors, government, universities, and research institutions utilize these instruments for drug safety, automated solutions, and data analysis. In addition, clinical analyzers are essential in hospitals for public health emergencies and diagnostic purposes. Theoretical research and remodeling also benefit from these tools, ensuring accuracy and advancing scientific knowledge.

Market Research Overview

The scientific instrument market encompasses a wide range of products designed for measuring, analyzing, and verifying physical quantities in various fields. Key product categories include Microscopes (Product and Electron), Spectrometers (Handheld, Benchtop, and Portable), X-ray Diffraction, Thermal Analyzers, and various analyzers like Chromatographs and Particle Analyzers. These instruments find applications in laboratories, healthcare companies, retail and online sales, biotechnology, materials science, environmental science, private organizations, academic institutions, and pharmaceutical companies. Areas of focus include biomarker detection systems, drug development, molecular interactions, biological processes, disease mechanisms, genomics and proteomics, drug discovery, personalized healthcare, and quality control. Additionally, scientific instruments are used in aerospace engineering for cameras, celestial bodies, and planetary exploration, as well as in avionics technology and environmental monitoring. In the healthcare sector, instruments are used for medical diagnosis, treatment planning, infectious diseases, clinical laboratories, and cancer research. In the pharmaceutical sector, instruments play a crucial role in drug safety, automated solutions, data analysis, and pharmaceutical research. The market also includes startups, focusing on areas like drug safety, precision medicine, and automation. Instruments are used in various sectors like chromatographs, particle analyzers, scientific clinical analyzers, and for analyzing biological samples like blood, urine, and tissue. Instruments are used to measure and analyze glucose levels, cholesterol levels, and blood cell counts, among other physical quantities. The market also includes instruments for remodeling, theoretical research, and measuring various physical quantities. In summary, the scientific instrument market caters to a diverse range of applications and industries, enabling advancements in fields like biotechnology, healthcare, pharmaceuticals, and aerospace engineering.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ProductLaboratory Analytical Instruments And ConsumablesMeasuring And Monitoring DevicesEnd-userPharmaceutical And Biotechnology CompaniesHospitals And Diagnostic LaboratoriesOthersGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/scientific-instrument-market-size-is-set-to-grow-by-usd-19-96-billion-from-2024-2028–increasing-investments-in-drug-discovery-boost-the-market-technavio-302210020.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Flō Networks Announces Intention to Launch Public Tender Offers to Acquire Up to 100% of Controladora Axtel, S.A.B. de C.V. and Axtel, S.A.B. de C.V.

Published

on

By

MEXICO CITY and EL PASO, Texas, Sept. 1, 2026 /CNW/ — Transtelco Holding, Inc. (doing business as Flō Networks, or “Flō”), a U.S.-based, independent digital infrastructure provider operating its own fiber-optic network across Mexico, the Southwestern United States and Latin America, today announced its intention to launch concurrent public tender offers (ofertas públicas de adquisición, or the “Offers”) to acquire up to 100% of the outstanding shares of Controladora Axtel, S.A.B. de C.V. (“Controladora Axtel”) and up to 100% of the outstanding CPOs of Axtel, S.A.B. de C.V. (“Axtel,” and together with Controladora Axtel, the “Axtel Companies”).

Flō has received preliminary approval from the Boards of Directors of both Axtel Companies to continue the process

Flō has received preliminary approval from the Boards of Directors of both Axtel Companies to continue the process toward launching the Offers, and is working to obtain the required regulatory approvals.

The commencement of the Offers remains subject to authorization by the Comisión Nacional Bancaria y de Valores, clearance by the Comisión Nacional Antimonopolio, the receipt of any other required regulatory approvals, and the satisfaction of the applicable contractual and corporate conditions. Subject to the satisfaction of these requirements, Flō is prepared to move promptly toward commencement of the Offers. The terms and conditions of the Offers, including the applicable offering documents, will be published in accordance with Mexican securities laws and the regulations of the Bolsa Mexicana de Valores at the appropriate time.

“This is an important step in our long-term vision for Flō and for the digital infrastructure that will support Mexico’s continued economic and technological development,” said Miguel Fernandez, Chief Executive Officer of Flō Networks. “By bringing together the complementary networks, capabilities and talent of Flō and Axtel, we have an opportunity to create a stronger digital infrastructure platform with greater scale, reach and capacity to serve customers across Mexico and beyond. We believe that stronger infrastructure enables stronger businesses, greater innovation and new opportunities for the communities and economies we connect.”

The proposed acquisition would combine complementary assets and expertise to strengthen Flō’s ability to invest in network resilience, expand its portfolio of digital services and deliver greater value to businesses operating in Mexico and across the region. Flō believes the combination would create meaningful operational and commercial synergies while supporting continued investment in the infrastructure required for critical technologies for productivity and competitiveness. The transaction would also create opportunities for long-term value creation for customers, employees, shareholders, partners and the communities the companies serve.

About Flō Networks

Founded as Transtelco in 2001, Flō Networks is a leading digital infrastructure provider connecting companies on both sides of the U.S.-Mexico border and across the Americas. Flō provides comprehensive connectivity solutions and advanced cloud infrastructure to Fortune 500 companies, telecommunications providers and cable operators through a fiber-optic network spanning more than 30,000 route miles across the Southwestern United States and Mexico, with connectivity across fifteen countries throughout the Americas. For more information, visit flo.net.

View original content to download multimedia:https://www.prnewswire.com/news-releases/fl-networks-announces-intention-to-launch-public-tender-offers-to-acquire-up-to-100-of-controladora-axtel-sab-de-cv-and-axtel-sab-de-cv-302866536.html

SOURCE Flō Networks

Continue Reading

Technology

Arista Demand Hires Jordanna Howard to Strengthen the Company’s Continued Growth

Published

on

By

SAN FRANCISCO, Sept. 1, 2026 /PRNewswire/ — Arista Demand, a leading provider of B2B demand generation solutions, is pleased to announce Jordanna Howard has joined the company as VP, Global Integrated Sales, effective September 1, 2026.

Prior to joining Arista Demand, Jordanna spent five years at Veritas Media Group, serving as VP of Client Services. Jordanna played a key part in growing VMG’s client portfolio and driving net-new revenue through new business partnerships, while also expanding and strengthening existing client relationships. She was instrumental in championing VMG’s reputation for white-glove service, exceptional client experiences, and long-term client success.

Jordanna joins Arista Demand as the organization continues to expand its capabilities, strengthen and build client partnerships, and help B2B organizations connect with the right prospects through results-driven demand generation and media initiatives.

“We are thrilled to welcome Jordanna to Arista Demand,” said Managing Director, Jennifer Sand. “She brings tremendous experience, energy, and a client-focused approach that aligns perfectly with how we work. Jordanna will be an important part of our continued growth, and we’re excited to have her on the team.”

In her new role, Jordanna will focus on client development, partnerships, and sales. Her experience in digital and non-traditional media will further strengthen Arista Demand’s ability to deliver innovative and integrated, measurable solutions, beyond lead gen, for clients.

“I’m excited to join Arista Demand and become part of a team that is so focused on its clients and their success,” said Howard. “I look forward to contributing to the company’s growth and helping our clients achieve meaningful results.”

Jordanna lives in Napa, California, with her partner, Jeff, and daughter, Mackie. Outside of work, she loves spending time with family and friends and is passionate about giving back.

She serves on UCSF’s Board of Directors for “All May See” vision foundation as well as sfBIG’s Board, supporting and connecting the Bay Area advertising community. Jordanna is also actively involved in her daughter’s school and is the troop leader for her local Girl Scouts Brownie troop.

About Arista Demand

Arista Demand helps B2B organizations accelerate revenue through intent targeted demand generation programs designed to connect brands with their respective audience that matter most. Through a combination of intent, 1st party data, strategy, technology, and client-focused execution, Arista Demand helps marketers build pipeline and drive measurable business results. Arista Demand brings buyers and sellers together around the globe. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/arista-demand-hires-jordanna-howard-to-strengthen-the-companys-continued-growth-302865498.html

SOURCE Arista Demand

Continue Reading

Technology

Reducto Unveils a Frontier Parsing Model That Makes the World’s Hardest Documents AI-Ready for 1¢ a Page

Published

on

By

The new r-1 model is the first in a family of document intelligence models that reduces parsing errors by up to 20% while replacing complex, multi-tool pipelines with a single model that costs up to 6× less.

SAN FRANCISCO, Sept. 1, 2026 /PRNewswire/ — Reducto today introduced r-1, a frontier document parsing model that turns complex PDFs, scans, spreadsheets, and other files into accurate, structured data for AI systems.

Reducto has already established itself as a leader in document parsing by handling the long tail of complex files that break conventional tools. Available today in preview, r-1 extends that lead—reducing errors by up to 20%, improving latency at high volumes, and bringing the all-in cost down to 1¢ per page.

Before an AI system can reason over a document, it must first understand what is on the page. That becomes difficult when meaning is encoded not only in text, but also in tables, handwriting, reading order, formatting, checkboxes, strikethroughs, and the position of content. A parser that misreads a financial table can give an AI agent the wrong numbers. One that drops a strikethrough can reverse the meaning of a contract.

Established services such as Amazon Textract and Azure Document Intelligence helped make cloud document processing widely available. But organizations working with complex documents often still combine multiple tools, models, and layers of post-processing to achieve the accuracy they need. In Reducto’s evaluations, r-1 outperformed commonly used hyper-scaler products and large LLMs on complex documents while providing a complete parse at one all-in price.

Built from the ground up and trained on some of the most challenging document data in the world, r-1 combines layout detection, reading order, tables, formatting, grounding, and granular citations in a single model. It is designed for the long tail of documents where simpler parsers break down, including dense tables, unusual layouts, low-quality scans, handwriting, watermarked content, and files that do not follow predictable templates.

By combining these capabilities, r-1 can handle an organization’s full document workload without requiring teams to route files among providers or maintain separate pipelines for different document types. Its flat price of 1¢ per page includes the complete parse, without additional model charges or feature-based multipliers.

r-1 is the first in a broader family of Reducto parsing models designed for different points on the accuracy, latency, and cost curve. Planned additions include r-1 mini, a smaller model for speed- and cost-sensitive workloads, and automatic routing that selects the right model for each page.

Organizations using another parser can receive up to $5,000 in credits to test r-1 on their most difficult documents, along with hands-on benchmarking support, at reducto.ai/migrate. r-1 is also available today in preview through a configuration flag in the Reducto Parse API.

About Reducto

Reducto is an agentic document platform that turns complex, real-world documents into structured data for AI agents and document-intensive workflows. The company has raised more than $108 million from investors including Andreessen Horowitz and First Round Capital and has processed more than a billion pages a month. Its customers include Harvey, Scale AI, Vanta, Airtable, Toast, and Fortune 10 enterprises.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/reducto-unveils-a-frontier-parsing-model-that-makes-the-worlds-hardest-documents-ai-ready-for-1-a-page-302866077.html

SOURCE Reducto

Continue Reading

Trending